Expiration date: 05/2025

Action:

hypotensive effect

Composition:

Valsartan 80 and 160 mg

Auxiliary substances: microcrystalline cellulose, silica colloidal anhydrous, sorbitol, corn starch, povidone, sodium fumarate, sodium lauryl sulfate

Indications:

• Treatment of hypertension
  
• The treatment of chronic heart failure (II-IV functional class classification NYHA) in patients receiving conventional therapy with diuretics, digitalis preparations, and ACE inhibitors or beta-blockers.